© 2020 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Stephen Huber
Articles
Basal cell carcinoma treatments on the horizon
June 13, 2019
In this pipeline report, Dermatology Times presents insights into Hh pathway inhibitors currently in phase 2 and phase 3 for the treatment of basal cell carcinoma.
What's new in melanoma treatment?
June 13, 2019
Innovative melanoma therapeutics are on the horizon. This pipeline report highlights some of the new drugs currently in phase 2, phase 3 or recently approved for the treatment of melanoma.